Member Info for Dibs61

Looks like one or two who clearly bought speculatively yesterday have bailed out this morning. Clearly someone who understands nothing of the fundamentals here. Shame. CD4 remains the jewel in the crown here and await positive developments.

Probably not. No results due for some time now.

Check out following UNICEF product analysis for all leading CD4 POC products: https://www.unicef.org/videoaudio/PDFs/CD4_POC_Technology_performance_characteristics_2015.pdf Omegas Visitect CD4 is the ONLY product which offers a truly mobile hand held disposable device suitable for the huge market demand for resource limited settings - and it is edging nearer to both CE marking and WHO prerequisite These approvals are expected before end this year - then NGO's and other charity organisations can commence larger volume orders for Visitect CD4 CD4 POC market expected to grow at a CAGR of 10.% pa for next few years

Omega Diagnostics are the ONLY company with a specific POC test which is completely suited for the much needed market demand for remote location settings (in particular) but also any other setting. Results in minutes. Competitive cost - roughly same as existing lab tests - possibly slightly cheaper. Technology is equiv to gold standard lab tests. Quote from WHO report on CD4 POC tests: (link attached) "The largest increase in CD4 test volumes will be driven by the adoption of POC devices, including device free technologies, in either scenario (either scenario meaning low or high growth take up) http://www.who.int/hiv/amds/110_Diagnostics-Manufacturer-Stakeholder-Meeting_CHAI.pdf This is a company transforming product on the cusp of commercialisation- CE mark due by end this year.

Bio - how right you were 👍🏻 And up we go. No spare stock here.

25k buy @ 23.5p - well above quoted ask. Someone's prepared to pay a pretty premium for these ;)

£11.75k delayed buy at a full penny above quoted ask @ 23.5p. Nice 👍🏻

Astonishingly under the radar. Mammoth growth potential clearly now being recognised by the market. Chart breakout + rerating in progress

THREE RNS's in a week. AN on Proactive..... Classic AIM company strategy preceding a placing. And it's all been done one too many times and the market knows it.

Tipping point for music industry. And even minnows like OMIP are likely to benefit. https://www.theguardian.com/business/2017/apr/25/2016-marks-tipping-point-for-music-industry-with-revenues-of-15bn

Indicator of continued expansion = growth. ;)

Yes! Not before time. Small buys but prob not a lot of stock knocking around.

Somewhat belatedly this morning :( saw it moving but didnt act initially arrrgghh Hoping for some more upside. SP is still substantially lower than last time Tungsten price was this high. Nice delayed £12k buy btw

This is all to do with the rising APT price

Not exactly creeping, yesterday was 15% rise! But I take your point. What is most impressive is its rising on very respectable volume. Looks to have broken out from chart perspective. But best of all, no herd!

When there's a scramble for the door one must always try and be first not last ;) But seriously well done on your trade and enjoy the bubbly :)

nm

And 'if' the PVR drill is successful then that provides an additional substantial boost of interest here, rest assured ;)

This is currently rock bottom. All important Woodside 3D seismic results due this month. Positive outcome could at least double SP here.

IMO. Company is debt free. CEO is very competent and has guided company through a huge transition in the music industry - downloads to streaming. Risk : stock can be very illiquid BUT with patience def multi bagger potential with 1-2 yr view Don't bother unless you are patient